JP2006503010A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006503010A5 JP2006503010A5 JP2004529004A JP2004529004A JP2006503010A5 JP 2006503010 A5 JP2006503010 A5 JP 2006503010A5 JP 2004529004 A JP2004529004 A JP 2004529004A JP 2004529004 A JP2004529004 A JP 2004529004A JP 2006503010 A5 JP2006503010 A5 JP 2006503010A5
- Authority
- JP
- Japan
- Prior art keywords
- imidazo
- pyridin
- bromo
- phenyl
- phenoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 methoxyphenyl Chemical group 0.000 claims description 99
- 125000000217 alkyl group Chemical group 0.000 claims description 86
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 72
- 125000001072 heteroaryl group Chemical group 0.000 claims description 51
- 229910052736 halogen Inorganic materials 0.000 claims description 47
- 229910052799 carbon Inorganic materials 0.000 claims description 46
- 125000005842 heteroatom Chemical group 0.000 claims description 46
- 229910052760 oxygen Inorganic materials 0.000 claims description 46
- 229910052717 sulfur Inorganic materials 0.000 claims description 46
- 150000002367 halogens Chemical class 0.000 claims description 41
- 229910052757 nitrogen Inorganic materials 0.000 claims description 37
- 229910052739 hydrogen Inorganic materials 0.000 claims description 33
- 125000003545 alkoxy group Chemical group 0.000 claims description 29
- 150000001875 compounds Chemical class 0.000 claims description 20
- 229920006395 saturated elastomer Polymers 0.000 claims description 19
- 125000001041 indolyl group Chemical group 0.000 claims description 16
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 13
- 125000000623 heterocyclic group Chemical group 0.000 claims description 13
- 125000001424 substituent group Chemical group 0.000 claims description 13
- 125000004076 pyridyl group Chemical group 0.000 claims description 9
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims description 8
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 8
- 125000000335 thiazolyl group Chemical group 0.000 claims description 8
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 5
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 claims description 5
- 125000003386 piperidinyl group Chemical group 0.000 claims description 5
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 5
- 125000001425 triazolyl group Chemical group 0.000 claims description 5
- 239000004593 Epoxy Substances 0.000 claims description 3
- 125000000304 alkynyl group Chemical group 0.000 claims description 3
- 125000001589 carboacyl group Chemical group 0.000 claims description 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 3
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 3
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 3
- 125000001624 naphthyl group Chemical group 0.000 claims description 3
- 125000001113 thiadiazolyl group Chemical group 0.000 claims description 3
- 125000004429 atom Chemical group 0.000 claims description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 35
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 26
- 150000001412 amines Chemical class 0.000 claims 21
- 150000003839 salts Chemical class 0.000 claims 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 9
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 5
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 3
- YVPZMBWNDMKAFG-UHFFFAOYSA-N 2-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-n-(oxolan-2-ylmethyl)ethanamine Chemical compound N=1C2=CC(Br)=CN=C2NC=1C(C=C1)=CC=C1OCCNCC1CCCO1 YVPZMBWNDMKAFG-UHFFFAOYSA-N 0.000 claims 2
- 125000003852 3-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])* 0.000 claims 2
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 claims 2
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzenecarbonitrile Natural products N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims 2
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims 1
- XOFXOXYZRJFXAA-UHFFFAOYSA-N 1-[2-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]ethyl]-4-phenylpiperidin-4-ol Chemical compound C1CN(CCOC=2C=CC(=CC=2)C=2NC3=NC=C(Br)C=C3N=2)CCC1(O)C1=CC=CC=C1 XOFXOXYZRJFXAA-UHFFFAOYSA-N 0.000 claims 1
- AATVNHFGOQFNAZ-UHFFFAOYSA-N 1-[2-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]ethyl]-n,n-dimethylpyrrolidin-3-amine Chemical compound C1C(N(C)C)CCN1CCOC1=CC=C(C=2NC3=NC=C(Br)C=C3N=2)C=C1 AATVNHFGOQFNAZ-UHFFFAOYSA-N 0.000 claims 1
- WPRYBCGWQBDPQL-UHFFFAOYSA-N 1-[2-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]ethylamino]propan-2-ol Chemical compound C1=CC(OCCNCC(O)C)=CC=C1C1=NC2=CC(Br)=CN=C2N1 WPRYBCGWQBDPQL-UHFFFAOYSA-N 0.000 claims 1
- SGIZUJXDBSCNTD-UHFFFAOYSA-N 1-[2-[[3-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-2-hydroxypropyl]amino]ethyl]imidazolidin-2-one Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CNCCN1CCNC1=O SGIZUJXDBSCNTD-UHFFFAOYSA-N 0.000 claims 1
- FRVGUTJAGGXEQH-UHFFFAOYSA-N 1-[3-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-2-hydroxypropyl]-4-phenylpiperidin-4-ol Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CN(CC1)CCC1(O)C1=CC=CC=C1 FRVGUTJAGGXEQH-UHFFFAOYSA-N 0.000 claims 1
- XRRXYCPDSISAKX-UHFFFAOYSA-N 1-[3-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-2-hydroxypropyl]piperidin-3-ol Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CN1CCCC(O)C1 XRRXYCPDSISAKX-UHFFFAOYSA-N 0.000 claims 1
- YFWLOOOZFUSXRK-UHFFFAOYSA-N 1-[3-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-2-hydroxypropyl]pyrrolidin-3-ol Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CN1CCC(O)C1 YFWLOOOZFUSXRK-UHFFFAOYSA-N 0.000 claims 1
- UUJHKACVKQWFNA-UHFFFAOYSA-N 1-[3-[[3-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-2-hydroxypropyl]amino]propyl]pyrrolidin-2-one Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CNCCCN1CCCC1=O UUJHKACVKQWFNA-UHFFFAOYSA-N 0.000 claims 1
- VBKMXWUNMYJLFJ-UHFFFAOYSA-N 1-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-3-(1,3-thiazol-2-ylamino)propan-2-ol Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CNC1=NC=CS1 VBKMXWUNMYJLFJ-UHFFFAOYSA-N 0.000 claims 1
- PCNWIJAUTHPDOB-UHFFFAOYSA-N 1-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-3-(2-morpholin-4-ylethylamino)propan-2-ol Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CNCCN1CCOCC1 PCNWIJAUTHPDOB-UHFFFAOYSA-N 0.000 claims 1
- DKRZCPMSDRPUKY-UHFFFAOYSA-N 1-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-3-(2-pyridin-3-ylpiperidin-1-yl)propan-2-ol Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CN1CCCCC1C1=CC=CN=C1 DKRZCPMSDRPUKY-UHFFFAOYSA-N 0.000 claims 1
- KDXGEYZJCDCCQS-UHFFFAOYSA-N 1-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-3-(cyclopropylamino)propan-2-ol Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CNC1CC1 KDXGEYZJCDCCQS-UHFFFAOYSA-N 0.000 claims 1
- ZVWDFMPWYLNSBM-UHFFFAOYSA-N 1-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-3-(pyridin-3-ylmethylamino)propan-2-ol Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CNCC1=CC=CN=C1 ZVWDFMPWYLNSBM-UHFFFAOYSA-N 0.000 claims 1
- JMQGGIWFJJIZNK-UHFFFAOYSA-N 1-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-3-(pyridin-4-ylmethylamino)propan-2-ol Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CNCC1=CC=NC=C1 JMQGGIWFJJIZNK-UHFFFAOYSA-N 0.000 claims 1
- GLRMASZSUMHSJM-UHFFFAOYSA-N 1-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-3-[(1-ethylpiperidin-3-yl)amino]propan-2-ol Chemical compound C1N(CC)CCCC1NCC(O)COC1=CC=C(C=2NC3=NC=C(Br)C=C3N=2)C=C1 GLRMASZSUMHSJM-UHFFFAOYSA-N 0.000 claims 1
- SEIDDLKXHXRNFT-UHFFFAOYSA-N 1-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-3-[2-(hydroxymethyl)piperidin-1-yl]propan-2-ol Chemical compound OCC1CCCCN1CC(O)COC1=CC=C(C=2NC3=NC=C(Br)C=C3N=2)C=C1 SEIDDLKXHXRNFT-UHFFFAOYSA-N 0.000 claims 1
- IYQWHRBFNVYLHV-UHFFFAOYSA-N 1-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-3-[2-hydroxyethyl(methyl)amino]propan-2-ol Chemical compound C1=CC(OCC(O)CN(CCO)C)=CC=C1C1=NC2=CC(Br)=CN=C2N1 IYQWHRBFNVYLHV-UHFFFAOYSA-N 0.000 claims 1
- AMLDURGYWOQNQE-UHFFFAOYSA-N 1-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-3-[4-(hydroxymethyl)piperidin-1-yl]propan-2-ol Chemical compound C1CC(CO)CCN1CC(O)COC1=CC=C(C=2NC3=NC=C(Br)C=C3N=2)C=C1 AMLDURGYWOQNQE-UHFFFAOYSA-N 0.000 claims 1
- OTXXKRHRGXTAKE-UHFFFAOYSA-N 1-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-3-[methyl(2-phenylethyl)amino]propan-2-ol Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CN(C)CCC1=CC=CC=C1 OTXXKRHRGXTAKE-UHFFFAOYSA-N 0.000 claims 1
- QAVCGRXNLMKXHJ-UHFFFAOYSA-N 1-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-3-morpholin-4-ylpropan-2-ol Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CN1CCOCC1 QAVCGRXNLMKXHJ-UHFFFAOYSA-N 0.000 claims 1
- CEFDJXPPCNJATN-UHFFFAOYSA-N 1-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-3-piperidin-1-ylpropan-2-ol Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CN1CCCCC1 CEFDJXPPCNJATN-UHFFFAOYSA-N 0.000 claims 1
- QTJYJMSQCUGYRB-UHFFFAOYSA-N 1-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-3-pyrrolidin-1-ylpropan-2-ol Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CN1CCCC1 QTJYJMSQCUGYRB-UHFFFAOYSA-N 0.000 claims 1
- JYDBGXIVWJGCCL-UHFFFAOYSA-N 1-[6-chloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1h-imidazo[4,5-b]pyridin-7-yl]pyrrolidin-3-amine Chemical compound C1C(N)CCN1C1=C(Cl)C=NC2=C1NC(C=1C=CC(OCCN3CCOCC3)=CC=1)=N2 JYDBGXIVWJGCCL-UHFFFAOYSA-N 0.000 claims 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000003287 1H-imidazol-4-ylmethyl group Chemical group [H]N1C([H])=NC(C([H])([H])[*])=C1[H] 0.000 claims 1
- HGMKRZLUXLXGKO-UHFFFAOYSA-N 2-(4-aminophenyl)-6-chloro-n-phenyl-1h-imidazo[4,5-b]pyridin-7-amine Chemical compound C1=CC(N)=CC=C1C(NC1=NC=C2Cl)=NC1=C2NC1=CC=CC=C1 HGMKRZLUXLXGKO-UHFFFAOYSA-N 0.000 claims 1
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 claims 1
- 125000006282 2-chlorobenzyl group Chemical group [H]C1=C([H])C(Cl)=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- OHJVBZCLUWFMAS-UHFFFAOYSA-N 3-[[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)anilino]methyl]benzonitrile Chemical compound N=1C2=CC(Br)=CN=C2NC=1C(C=C1)=CC=C1NCC1=CC=CC(C#N)=C1 OHJVBZCLUWFMAS-UHFFFAOYSA-N 0.000 claims 1
- 125000006497 3-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims 1
- YQLCRRXQGXERBZ-UHFFFAOYSA-N 4-(6,7-dichloro-1h-imidazo[4,5-b]pyridin-2-yl)-n-(2-morpholin-4-ylethyl)aniline Chemical compound N=1C2=C(Cl)C(Cl)=CN=C2NC=1C(C=C1)=CC=C1NCCN1CCOCC1 YQLCRRXQGXERBZ-UHFFFAOYSA-N 0.000 claims 1
- BWOOCQOEKQYBTE-UHFFFAOYSA-N 4-(6-bromo-7-methyl-1h-imidazo[4,5-b]pyridin-2-yl)aniline Chemical compound N1C=2C(C)=C(Br)C=NC=2N=C1C1=CC=C(N)C=C1 BWOOCQOEKQYBTE-UHFFFAOYSA-N 0.000 claims 1
- SCMPKZNANUSIEJ-UHFFFAOYSA-N 4-(6-chloro-7-methyl-1h-imidazo[4,5-b]pyridin-2-yl)-1-n-(2-morpholin-4-ylethyl)benzene-1,2-diamine Chemical compound N=1C=2C(C)=C(Cl)C=NC=2NC=1C(C=C1N)=CC=C1NCCN1CCOCC1 SCMPKZNANUSIEJ-UHFFFAOYSA-N 0.000 claims 1
- RXXAZAOOQHNXPX-UHFFFAOYSA-N 4-[2-[4-(6-chloro-7-methoxy-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]ethyl]morpholine Chemical compound N=1C=2C(OC)=C(Cl)C=NC=2NC=1C(C=C1)=CC=C1OCCN1CCOCC1 RXXAZAOOQHNXPX-UHFFFAOYSA-N 0.000 claims 1
- JJDVDAYTHAFKKJ-UHFFFAOYSA-N 4-[2-[4-(6-chloro-7-phenoxy-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]ethyl]morpholine Chemical compound ClC1=CN=C2N=C(C=3C=CC(OCCN4CCOCC4)=CC=3)NC2=C1OC1=CC=CC=C1 JJDVDAYTHAFKKJ-UHFFFAOYSA-N 0.000 claims 1
- KNIOJIRSCQWGGB-UHFFFAOYSA-N 4-[2-[4-(6-chloro-7-pyrrol-1-yl-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]ethyl]morpholine Chemical compound ClC1=CN=C2N=C(C=3C=CC(OCCN4CCOCC4)=CC=3)NC2=C1N1C=CC=C1 KNIOJIRSCQWGGB-UHFFFAOYSA-N 0.000 claims 1
- WVUAPIBWFHEWMI-UHFFFAOYSA-N 4-[2-[4-(6-chloro-7-pyrrolidin-1-yl-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]ethyl]morpholine Chemical compound ClC1=CN=C2NC(C=3C=CC(OCCN4CCOCC4)=CC=3)=NC2=C1N1CCCC1 WVUAPIBWFHEWMI-UHFFFAOYSA-N 0.000 claims 1
- WQPNRHACZCAEHS-UHFFFAOYSA-N 4-[2-[4-(7-benzylsulfanyl-6-chloro-1H-imidazo[4,5-b]pyridin-2-yl)phenoxy]ethyl]morpholine 6-chloro-N-methyl-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1H-imidazo[4,5-b]pyridin-7-amine Chemical compound C(C1=CC=CC=C1)SC1=C2C(=NC=C1Cl)N=C(N2)C2=CC=C(C=C2)OCCN2CCOCC2.ClC=2C(=C1C(=NC2)N=C(N1)C1=CC=C(C=C1)OCCN1CCOCC1)NC WQPNRHACZCAEHS-UHFFFAOYSA-N 0.000 claims 1
- WHOGMXGOVZDSCZ-UHFFFAOYSA-N 4-[2-[4-[6-chloro-7-(2,3-dihydroindol-1-yl)-1h-imidazo[4,5-b]pyridin-2-yl]phenoxy]ethyl]morpholine Chemical compound N1C2=C(N3C4=CC=CC=C4CC3)C(Cl)=CN=C2N=C1C(C=C1)=CC=C1OCCN1CCOCC1 WHOGMXGOVZDSCZ-UHFFFAOYSA-N 0.000 claims 1
- MEVPMQHLJLPVST-UHFFFAOYSA-N 4-[2-[4-[6-chloro-7-(2-pyrrolidin-1-ylethoxy)-1h-imidazo[4,5-b]pyridin-2-yl]phenoxy]ethyl]morpholine Chemical compound ClC1=CN=C2N=C(C=3C=CC(OCCN4CCOCC4)=CC=3)NC2=C1OCCN1CCCC1 MEVPMQHLJLPVST-UHFFFAOYSA-N 0.000 claims 1
- RSYMBCFJZVPQTO-UHFFFAOYSA-N 4-[4-(6,7-dichloro-1h-imidazo[4,5-b]pyridin-2-yl)phenyl]morpholine Chemical compound N1C2=C(Cl)C(Cl)=CN=C2N=C1C(C=C1)=CC=C1N1CCOCC1 RSYMBCFJZVPQTO-UHFFFAOYSA-N 0.000 claims 1
- MKDIXOUTQXWDIJ-UHFFFAOYSA-N 4-[6-chloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1h-imidazo[4,5-b]pyridin-7-yl]morpholine Chemical compound ClC1=CN=C2N=C(C=3C=CC(OCCN4CCOCC4)=CC=3)NC2=C1N1CCOCC1 MKDIXOUTQXWDIJ-UHFFFAOYSA-N 0.000 claims 1
- YVHCOSCTWPGEBH-UHFFFAOYSA-N 4-[[3-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-2-hydroxypropyl]-methylamino]cyclohexane-1-carbonitrile Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CN(C)C1CCC(C#N)CC1 YVHCOSCTWPGEBH-UHFFFAOYSA-N 0.000 claims 1
- RUWVZPKTGUZGMK-UHFFFAOYSA-N 4-[[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)anilino]methyl]benzonitrile Chemical compound N=1C2=CC(Br)=CN=C2NC=1C(C=C1)=CC=C1NCC1=CC=C(C#N)C=C1 RUWVZPKTGUZGMK-UHFFFAOYSA-N 0.000 claims 1
- ORJAOCKIDKOPHY-UHFFFAOYSA-N 5-(6-chloro-7-methyl-1h-imidazo[4,5-b]pyridin-2-yl)-2-(4-methylpiperazin-1-yl)aniline Chemical compound C1CN(C)CCN1C1=CC=C(C=2NC3=NC=C(Cl)C(C)=C3N=2)C=C1N ORJAOCKIDKOPHY-UHFFFAOYSA-N 0.000 claims 1
- RPLRBNKLWIKWBK-UHFFFAOYSA-N 6-[4-[3-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]-2-hydroxypropyl]piperazin-1-yl]pyridine-3-carbonitrile Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCC(O)CN(CC1)CCN1C1=CC=C(C#N)C=N1 RPLRBNKLWIKWBK-UHFFFAOYSA-N 0.000 claims 1
- LFJQIBWZHWLOGT-UHFFFAOYSA-N 6-bromo-2-[4-(3-pyrrolidin-1-ylpropoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=CC(Br)=CN=C2NC=1C(C=C1)=CC=C1OCCCN1CCCC1 LFJQIBWZHWLOGT-UHFFFAOYSA-N 0.000 claims 1
- LXYCSARZNPEDSO-UHFFFAOYSA-N 6-bromo-2-[4-[2-(4-pyridin-2-ylpiperazin-1-yl)ethoxy]phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=CC(Br)=CN=C2NC=1C(C=C1)=CC=C1OCCN(CC1)CCN1C1=CC=CC=N1 LXYCSARZNPEDSO-UHFFFAOYSA-N 0.000 claims 1
- YSVMAAIIFALTGL-UHFFFAOYSA-N 6-bromo-2-[4-[2-[4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]ethoxy]phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC(C(F)(F)F)=CN=C1N1CCN(CCOC=2C=CC(=CC=2)C=2NC3=NC=C(Br)C=C3N=2)CC1 YSVMAAIIFALTGL-UHFFFAOYSA-N 0.000 claims 1
- MJUAYHZFPGUPAX-UHFFFAOYSA-N 6-chloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-n-(1-phenylethyl)-1h-imidazo[4,5-b]pyridin-7-amine Chemical compound C=1C=CC=CC=1C(C)NC(C=1N=2)=C(Cl)C=NC=1NC=2C(C=C1)=CC=C1OCCN1CCOCC1 MJUAYHZFPGUPAX-UHFFFAOYSA-N 0.000 claims 1
- IKKUBYXKKDWVFN-UHFFFAOYSA-N 6-chloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-n-(2-morpholin-4-ylethyl)-1h-imidazo[4,5-b]pyridin-7-amine Chemical compound ClC1=CN=C2NC(C=3C=CC(OCCN4CCOCC4)=CC=3)=NC2=C1NCCN1CCOCC1 IKKUBYXKKDWVFN-UHFFFAOYSA-N 0.000 claims 1
- QBQUTQGXEHBFFO-UHFFFAOYSA-N 6-chloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-n-phenyl-1h-imidazo[4,5-b]pyridin-7-amine Chemical compound ClC1=CN=C2N=C(C=3C=CC(OCCN4CCOCC4)=CC=3)NC2=C1NC1=CC=CC=C1 QBQUTQGXEHBFFO-UHFFFAOYSA-N 0.000 claims 1
- NTYVMOUVGHNSCX-UHFFFAOYSA-N 6-chloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-n-pyridin-3-yl-1h-imidazo[4,5-b]pyridin-7-amine Chemical compound ClC1=CN=C2NC(C=3C=CC(OCCN4CCOCC4)=CC=3)=NC2=C1NC1=CC=CN=C1 NTYVMOUVGHNSCX-UHFFFAOYSA-N 0.000 claims 1
- SJMIFQGACFOHIW-UHFFFAOYSA-N 6-chloro-2-[4-(2-morpholin-4-ylethylamino)phenyl]-n-phenyl-1h-imidazo[4,5-b]pyridin-7-amine;n-[4-(6,7-dichloro-1h-imidazo[4,5-b]pyridin-2-yl)phenyl]-4-methoxybenzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NC1=CC=C(C=2NC3=C(Cl)C(Cl)=CN=C3N=2)C=C1.ClC1=CN=C2N=C(C=3C=CC(NCCN4CCOCC4)=CC=3)NC2=C1NC1=CC=CC=C1 SJMIFQGACFOHIW-UHFFFAOYSA-N 0.000 claims 1
- SCAPSICDJQLWAI-UHFFFAOYSA-N 6-chloro-n-(2-ethylphenyl)-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1h-imidazo[4,5-b]pyridin-7-amine Chemical compound CCC1=CC=CC=C1NC1=C(Cl)C=NC2=C1NC(C=1C=CC(OCCN3CCOCC3)=CC=1)=N2 SCAPSICDJQLWAI-UHFFFAOYSA-N 0.000 claims 1
- ANJGSAUNDPEGJJ-UHFFFAOYSA-N 6-chloro-n-(2-fluorophenyl)-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1h-imidazo[4,5-b]pyridin-7-amine Chemical compound FC1=CC=CC=C1NC1=C(Cl)C=NC2=C1N=C(C=1C=CC(OCCN3CCOCC3)=CC=1)N2 ANJGSAUNDPEGJJ-UHFFFAOYSA-N 0.000 claims 1
- LSYCABNSFISCPY-UHFFFAOYSA-N 6-chloro-n-(3-ethylphenyl)-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1h-imidazo[4,5-b]pyridin-7-amine Chemical compound CCC1=CC=CC(NC=2C=3NC(=NC=3N=CC=2Cl)C=2C=CC(OCCN3CCOCC3)=CC=2)=C1 LSYCABNSFISCPY-UHFFFAOYSA-N 0.000 claims 1
- YWSVZHHXLTVNBC-UHFFFAOYSA-N 6-chloro-n-(4-methylsulfonylphenyl)-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1h-imidazo[4,5-b]pyridin-7-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=C(Cl)C=NC2=C1NC(C=1C=CC(OCCN3CCOCC3)=CC=1)=N2 YWSVZHHXLTVNBC-UHFFFAOYSA-N 0.000 claims 1
- REDLVGATARAVSA-UHFFFAOYSA-N 7-anilino-2-[4-[2-[2-methoxyethyl(methyl)amino]ethoxy]phenyl]-1h-imidazo[4,5-b]pyridine-6-carbonitrile Chemical compound C1=CC(OCCN(C)CCOC)=CC=C1C(NC1=NC=C2C#N)=NC1=C2NC1=CC=CC=C1 REDLVGATARAVSA-UHFFFAOYSA-N 0.000 claims 1
- ORSZXLAEEIHIBA-UHFFFAOYSA-N 7-chloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1h-imidazo[4,5-b]pyridine-6-carbonitrile Chemical compound N=1C=2C(Cl)=C(C#N)C=NC=2NC=1C(C=C1)=CC=C1OCCN1CCOCC1 ORSZXLAEEIHIBA-UHFFFAOYSA-N 0.000 claims 1
- NDIZIKNUWOJLHQ-UHFFFAOYSA-N BrC=1C=C2C(=NC1)NC(=N2)C2=CC=C(OCCN1CCC(CC1)N1CCCCC1)C=C2.BrC=2C=C1C(=NC2)NC(=N1)C1=CC=C(OCCN2C(CCCC2)CO)C=C1 Chemical compound BrC=1C=C2C(=NC1)NC(=N2)C2=CC=C(OCCN1CCC(CC1)N1CCCCC1)C=C2.BrC=2C=C1C(=NC2)NC(=N1)C1=CC=C(OCCN2C(CCCC2)CO)C=C1 NDIZIKNUWOJLHQ-UHFFFAOYSA-N 0.000 claims 1
- QUPRPCBAYCKYEK-UHFFFAOYSA-N BrC=1C=C2C(=NC1)NC(=N2)C2=CC=C(OCCN1CCN(CC1)CCO)C=C2.BrC=2C=C1C(=NC2)NC(=N1)C1=CC=C(C=C1)OCCN1CCC(CC1)C1=C(C=CC=C1)OC Chemical compound BrC=1C=C2C(=NC1)NC(=N2)C2=CC=C(OCCN1CCN(CC1)CCO)C=C2.BrC=2C=C1C(=NC2)NC(=N1)C1=CC=C(C=C1)OCCN1CCC(CC1)C1=C(C=CC=C1)OC QUPRPCBAYCKYEK-UHFFFAOYSA-N 0.000 claims 1
- MHTCHYCFGVRSMI-UHFFFAOYSA-N C(C1=CC=CC=C1)NCC(COC1=CC=C(C=C1)C1=NC=2C(=NC=C(C2)Br)N1)O.BrC=1C=C2C(=NC1)NC(=N2)C2=CC=C(OCC(CNC(CO)C)O)C=C2 Chemical compound C(C1=CC=CC=C1)NCC(COC1=CC=C(C=C1)C1=NC=2C(=NC=C(C2)Br)N1)O.BrC=1C=C2C(=NC1)NC(=N2)C2=CC=C(OCC(CNC(CO)C)O)C=C2 MHTCHYCFGVRSMI-UHFFFAOYSA-N 0.000 claims 1
- HGNNAMTXEXMNAL-UHFFFAOYSA-N ClC=1C(=C2C(=NC1)N=C(N2)C2=CC=C(C=C2)OCCN2CCOCC2)NC2=C(C=CC=C2)OC.ClC=2C(=C1C(=NC2)NC(=N1)C1=CC=C(C=C1)OCCN1CCOCC1)Cl Chemical compound ClC=1C(=C2C(=NC1)N=C(N2)C2=CC=C(C=C2)OCCN2CCOCC2)NC2=C(C=CC=C2)OC.ClC=2C(=C1C(=NC2)NC(=N1)C1=CC=C(C=C1)OCCN1CCOCC1)Cl HGNNAMTXEXMNAL-UHFFFAOYSA-N 0.000 claims 1
- MPMIHCIYDGMTLC-UHFFFAOYSA-N ClC=1C(=C2C(=NC1)N=C(N2)C=2C=CC(=C(N)C2)OCCN2CCOCC2)Cl.ClC=2C(=C1C(=NC2)N=C(N1)C1=CC(=C(C=C1)OCCN1CCOCC1)[N+](=O)[O-])Cl Chemical compound ClC=1C(=C2C(=NC1)N=C(N2)C=2C=CC(=C(N)C2)OCCN2CCOCC2)Cl.ClC=2C(=C1C(=NC2)N=C(N1)C1=CC(=C(C=C1)OCCN1CCOCC1)[N+](=O)[O-])Cl MPMIHCIYDGMTLC-UHFFFAOYSA-N 0.000 claims 1
- JNXLGHBJPNHBNQ-UTONKHPSSA-N ClC=1C(=C2C(=NC1)NC(=N2)C=2C=CC(=C(C2)O)NC[C@@H]2NCCC2)C.NC2=C(C=C(C=C2)C2=NC=1C(=NC=C(C1C)Cl)N2)O Chemical compound ClC=1C(=C2C(=NC1)NC(=N2)C=2C=CC(=C(C2)O)NC[C@@H]2NCCC2)C.NC2=C(C=C(C=C2)C2=NC=1C(=NC=C(C1C)Cl)N2)O JNXLGHBJPNHBNQ-UTONKHPSSA-N 0.000 claims 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Natural products C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 1
- VPZONHBYECNKPC-UHFFFAOYSA-N N-[2-[4-(6-bromo-1H-imidazo[4,5-b]pyridin-2-yl)phenoxy]ethyl]cyclopentanamine 6-bromo-2-[4-[2-(2-pyridin-3-ylpiperidin-1-yl)ethoxy]phenyl]-1H-imidazo[4,5-b]pyridine Chemical compound BrC=1C=C2C(=NC1)NC(=N2)C2=CC=C(OCCNC1CCCC1)C=C2.BrC=2C=C1C(=NC2)NC(=N1)C1=CC=C(C=C1)OCCN1C(CCCC1)C=1C=NC=CC1 VPZONHBYECNKPC-UHFFFAOYSA-N 0.000 claims 1
- NXSZQWXQTAQARO-UHFFFAOYSA-N N1(CCOCC1)CCOC1=CC=C(C=C1)C1=NC=2C(=NC=C(C2C#N)C#N)N1.ClC=1C(=C2C(=NC1)NC(=N2)C2=CC=C(C=C2)OCCN2CCOCC2)C2=CSC=C2 Chemical compound N1(CCOCC1)CCOC1=CC=C(C=C1)C1=NC=2C(=NC=C(C2C#N)C#N)N1.ClC=1C(=C2C(=NC1)NC(=N2)C2=CC=C(C=C2)OCCN2CCOCC2)C2=CSC=C2 NXSZQWXQTAQARO-UHFFFAOYSA-N 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- APJYDQYYACXCRM-UHFFFAOYSA-N Tryptamine Natural products C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 claims 1
- PZNKARPNXABWEQ-UHFFFAOYSA-N [3-[[6-chloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1h-imidazo[4,5-b]pyridin-7-yl]amino]phenyl]methanol Chemical compound OCC1=CC=CC(NC=2C=3N=C(NC=3N=CC=2Cl)C=2C=CC(OCCN3CCOCC3)=CC=2)=C1 PZNKARPNXABWEQ-UHFFFAOYSA-N 0.000 claims 1
- UMAYBJRUVKEDAL-UHFFFAOYSA-N [5-[[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)anilino]methyl]furan-2-yl]methanol Chemical compound O1C(CO)=CC=C1CNC1=CC=C(C=2NC3=NC=C(Br)C=C3N=2)C=C1 UMAYBJRUVKEDAL-UHFFFAOYSA-N 0.000 claims 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 210000003651 basophil Anatomy 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 210000003630 histaminocyte Anatomy 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 125000003564 m-cyanobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(C#N)=C1[H])C([H])([H])* 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 150000002780 morpholines Chemical class 0.000 claims 1
- DCGKJYHNPRJSBB-UHFFFAOYSA-N n'-[2-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]ethyl]-n'-ethyl-n,n-dimethylethane-1,2-diamine Chemical compound C1=CC(OCCN(CC)CCN(C)C)=CC=C1C1=NC2=CC(Br)=CN=C2N1 DCGKJYHNPRJSBB-UHFFFAOYSA-N 0.000 claims 1
- HHGFLUSSFPHFPY-UHFFFAOYSA-N n-[1-[6-chloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1h-imidazo[4,5-b]pyridin-7-yl]pyrrolidin-3-yl]formamide Chemical compound ClC1=CN=C2N=C(C=3C=CC(OCCN4CCOCC4)=CC=3)NC2=C1N1CCC(NC=O)C1 HHGFLUSSFPHFPY-UHFFFAOYSA-N 0.000 claims 1
- QUSRVLXZSXFRQC-UHFFFAOYSA-N n-[2-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]ethyl]-1,3-thiazol-2-amine Chemical compound N=1C2=CC(Br)=CN=C2NC=1C(C=C1)=CC=C1OCCNC1=NC=CS1 QUSRVLXZSXFRQC-UHFFFAOYSA-N 0.000 claims 1
- DMBXOVNEKVFZEK-UHFFFAOYSA-N n-[2-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]ethyl]-4,5-dihydro-1,3-thiazol-2-amine Chemical compound N=1C2=CC(Br)=CN=C2NC=1C(C=C1)=CC=C1OCCNC1=NCCS1 DMBXOVNEKVFZEK-UHFFFAOYSA-N 0.000 claims 1
- SGICJQCHMPNALB-UHFFFAOYSA-N n-[2-[4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenoxy]ethyl]-n,1-dimethylpyrrolidin-3-amine Chemical compound C=1C=C(C=2NC3=NC=C(Br)C=C3N=2)C=CC=1OCCN(C)C1CCN(C)C1 SGICJQCHMPNALB-UHFFFAOYSA-N 0.000 claims 1
- KJLUYTCAIKAYIM-UHFFFAOYSA-N n-[3-[6-chloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1h-imidazo[4,5-b]pyridin-7-yl]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(C=2C=3N=C(NC=3N=CC=2Cl)C=2C=CC(OCCN3CCOCC3)=CC=2)=C1 KJLUYTCAIKAYIM-UHFFFAOYSA-N 0.000 claims 1
- GXRFSBVSAUKTBR-UHFFFAOYSA-N n-[4-(6-bromo-7-methyl-1h-imidazo[4,5-b]pyridin-2-yl)phenyl]-4-(2-cyanoethoxy)benzenesulfonamide Chemical compound N1C=2C(C)=C(Br)C=NC=2N=C1C(C=C1)=CC=C1NS(=O)(=O)C1=CC=C(OCCC#N)C=C1 GXRFSBVSAUKTBR-UHFFFAOYSA-N 0.000 claims 1
- CXONFAMPJGKMFF-UHFFFAOYSA-N n-[4-(6-bromo-7-methyl-1h-imidazo[4,5-b]pyridin-2-yl)phenyl]-4-methoxybenzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NC1=CC=C(C=2NC3=C(C)C(Br)=CN=C3N=2)C=C1 CXONFAMPJGKMFF-UHFFFAOYSA-N 0.000 claims 1
- NIRLLOGQPFCLQM-UHFFFAOYSA-N n-[4-(6-chloro-7-methoxy-1h-imidazo[4,5-b]pyridin-2-yl)phenyl]-4-cyanobenzenesulfonamide Chemical compound N1C=2C(OC)=C(Cl)C=NC=2N=C1C(C=C1)=CC=C1NS(=O)(=O)C1=CC=C(C#N)C=C1 NIRLLOGQPFCLQM-UHFFFAOYSA-N 0.000 claims 1
- RJSUMAYDGAKXMF-UHFFFAOYSA-N n-[4-[[6-chloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1h-imidazo[4,5-b]pyridin-7-yl]amino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC1=C(Cl)C=NC2=C1NC(C=1C=CC(OCCN3CCOCC3)=CC=1)=N2 RJSUMAYDGAKXMF-UHFFFAOYSA-N 0.000 claims 1
- ZDFVDUXGNJAWMH-UHFFFAOYSA-N n-benzyl-4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)aniline Chemical compound N=1C2=CC(Br)=CN=C2NC=1C(C=C1)=CC=C1NCC1=CC=CC=C1 ZDFVDUXGNJAWMH-UHFFFAOYSA-N 0.000 claims 1
- SSIFZJALHGDESM-UHFFFAOYSA-N n-benzyl-6-chloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1h-imidazo[4,5-b]pyridin-7-amine;6-chloro-n-cyclopentyl-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1h-imidazo[4,5-b]pyridin-7-amine Chemical compound ClC1=CN=C2N=C(C=3C=CC(OCCN4CCOCC4)=CC=3)NC2=C1NC1CCCC1.ClC1=CN=C2N=C(C=3C=CC(OCCN4CCOCC4)=CC=3)NC2=C1NCC1=CC=CC=C1 SSIFZJALHGDESM-UHFFFAOYSA-N 0.000 claims 1
- YCIFVSANVOFBMV-UHFFFAOYSA-N n-benzyl-6-chloro-n-methyl-2-[4-(2-morpholin-4-ylethoxy)phenyl]-1h-imidazo[4,5-b]pyridin-7-amine Chemical compound ClC=1C=NC=2N=C(C=3C=CC(OCCN4CCOCC4)=CC=3)NC=2C=1N(C)CC1=CC=CC=C1 YCIFVSANVOFBMV-UHFFFAOYSA-N 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical compound C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 claims 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0202462A SE0202462D0 (sv) | 2002-08-14 | 2002-08-14 | Novel use |
| PCT/SE2003/001279 WO2004016611A1 (en) | 2002-08-14 | 2003-08-13 | Use of and some novel imidazopyridines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006503010A JP2006503010A (ja) | 2006-01-26 |
| JP2006503010A5 true JP2006503010A5 (OSRAM) | 2006-09-28 |
Family
ID=20288750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004529004A Withdrawn JP2006503010A (ja) | 2002-08-14 | 2003-08-13 | 数種の新規なイミダゾピリジンおよびその使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7410966B2 (OSRAM) |
| EP (1) | EP1539759B1 (OSRAM) |
| JP (1) | JP2006503010A (OSRAM) |
| KR (1) | KR20060005333A (OSRAM) |
| CN (1) | CN100358893C (OSRAM) |
| AT (1) | ATE370138T1 (OSRAM) |
| AU (1) | AU2003251272A1 (OSRAM) |
| BR (1) | BR0313461A (OSRAM) |
| CA (1) | CA2495511A1 (OSRAM) |
| DE (1) | DE60315674T2 (OSRAM) |
| ES (1) | ES2290538T3 (OSRAM) |
| IL (1) | IL166413A0 (OSRAM) |
| MX (1) | MXPA05001581A (OSRAM) |
| NO (1) | NO20051265L (OSRAM) |
| NZ (1) | NZ538156A (OSRAM) |
| SE (1) | SE0202462D0 (OSRAM) |
| WO (1) | WO2004016611A1 (OSRAM) |
| ZA (1) | ZA200500887B (OSRAM) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06011021A (es) | 2004-03-25 | 2007-04-13 | Johnson & Johnson | Compuestos de imidazol. |
| JP2008503469A (ja) | 2004-06-17 | 2008-02-07 | ワイス | ゴナドトロピン放出ホルモン受容体アンタゴニスト |
| NZ552093A (en) | 2004-06-17 | 2009-06-26 | Wyeth Corp | Processes for preparing gonadotropin releasing hormone receptor antagonists |
| US7799778B1 (en) * | 2005-01-12 | 2010-09-21 | Alcon, Inc. | 5-substituted 2-aminopyridine analogs for treating allergic and inflammatory diseases |
| KR20060087386A (ko) | 2005-01-28 | 2006-08-02 | 주식회사 대웅제약 | 신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물 |
| US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7538113B2 (en) | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7582634B2 (en) | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| US7582636B2 (en) | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
| US8163767B2 (en) * | 2005-07-14 | 2012-04-24 | Astellas Pharma Inc. | Heterocyclic Janus Kinase 3 inhibitors |
| US7776878B2 (en) | 2005-08-01 | 2010-08-17 | Hoffmann-La Roche Inc. | Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents |
| BRPI0503681A (pt) * | 2005-08-19 | 2007-04-10 | Fundacao Oswaldo Cruz | compostos azóis usados como agentes tuberculostáticos e leishmanicidas, composições farmacêuticas contendo os mesmos, uso das respectivas composições farmacêuticas no tratamento ou inibição de doenças, bem como método de tratamento ou inibição de doenças |
| UY29823A1 (es) * | 2005-10-03 | 2007-05-31 | Astrazeneca Ab | Derivados sustituidos de 7-cloro-3h-imidazol-(4,5-b) piridina, composiciones farmacéuticas que los contienen, procesos para la preparación de los mismos y aplicaciones |
| AR055669A1 (es) * | 2005-10-03 | 2007-08-29 | Astrazeneca Ab | Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales. |
| ATE533485T1 (de) * | 2005-10-31 | 2011-12-15 | Merck Sharp & Dohme | Cetp-inhibitoren |
| JP5205276B2 (ja) * | 2005-12-22 | 2013-06-05 | ジ インスティテュート オブ キャンサー リサーチ：ロイヤル キャンサー ホスピタル | 酵素阻害剤 |
| EP1984370A4 (en) * | 2006-01-23 | 2010-03-31 | Crystalgenomics Inc | PROTEIN KINASE ACTIVITY INHIBITING IMIDAZOPYRIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF |
| ITMI20061581A1 (it) * | 2006-08-04 | 2008-02-05 | Univ Bari | Ligandi del recettore beta-3 adrenergico e loro uso in terapia |
| CN101657446B (zh) * | 2007-02-13 | 2013-05-15 | Ab科学有限公司 | 合成作为激酶抑制剂的2-氨基噻唑化合物的方法 |
| WO2008121064A1 (en) * | 2007-03-30 | 2008-10-09 | Astrazeneca Ab | New imidazo[4,5-b]pyridine-6-halo-7-aryl/heteroaryl compounds 705 |
| MX2009010165A (es) * | 2007-03-30 | 2009-10-12 | Astrazeneca Ab | Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704. |
| WO2009001021A1 (en) * | 2007-06-26 | 2008-12-31 | Chroma Therapeutics Ltd. | Imidazopyridine derivatives useful as enzyme inhibitors for the treatment of cell proliferative and autoimmune diseases |
| KR101703941B1 (ko) * | 2008-11-10 | 2017-02-07 | 내셔날 헬스 리서치 인스티튜트 | 티로신 키나아제 억제제로서의 접합 이환 및 삼환 피리미딘 화합물 |
| TWI461425B (zh) * | 2009-02-19 | 2014-11-21 | Janssen Pharmaceuticals Inc | 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類 |
| WO2012044043A2 (en) * | 2010-09-28 | 2012-04-05 | Daewoong Pharmaceutical Co., Ltd. | Novel method of preparing benzoimidazole derivatives |
| WO2013116291A1 (en) * | 2012-01-30 | 2013-08-08 | Cephalon, Inc. | Imidazo [4, 5 - b] pyridine derivatives as alk and jak modulators for the treatment of proliferative disorders |
| WO2013153539A1 (en) | 2012-04-13 | 2013-10-17 | Glenmark Pharmaceuticals S.A. | Tricyclic compounds as tec kinase inhibitors |
| CN103724331A (zh) * | 2012-10-11 | 2014-04-16 | 韩冰 | 一类治疗脑性瘫痪的化合物及其用途 |
| CN103800328A (zh) * | 2012-11-07 | 2014-05-21 | 韩冰 | 一类治疗神经退行性疾病的化合物及其用途 |
| GB201302927D0 (en) * | 2013-02-20 | 2013-04-03 | Cancer Therapeutics Crc Pty Ltd | Compounds |
| WO2014175370A1 (ja) * | 2013-04-25 | 2014-10-30 | 塩野義製薬株式会社 | ピロリジン誘導体およびそれらを含有する医薬組成物 |
| AU2014339815B2 (en) | 2013-10-25 | 2020-03-26 | Pharmacyclics Llc | Methods of treating and preventing graft versus host disease |
| US10005792B2 (en) | 2014-09-03 | 2018-06-26 | Ctxt Pty. Ltd. | Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitors |
| WO2016034673A1 (en) | 2014-09-03 | 2016-03-10 | Ctxt Pty Ltd | Tetrahydroisoquinoline derived prmt5-inhibitors |
| GB201415573D0 (en) | 2014-09-03 | 2014-10-15 | Cancer Therapeutics Crc Pty Ltd | Compounds |
| AU2016214492B2 (en) | 2015-02-02 | 2020-05-07 | Kancera Ab | 2-phenyl-3H-imidazo[4,5-b]pyridine derivates useful as inhibitors of mammalian tyrosine kinase ROR1activity |
| JP2018525411A (ja) | 2015-08-31 | 2018-09-06 | ファーマサイクリックス エルエルシー | 多発性骨髄腫を治療するためのｂｔｋ阻害剤の組み合わせ |
| GB201604022D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604031D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604029D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604020D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604027D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604030D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| US11008318B2 (en) | 2016-07-11 | 2021-05-18 | Kancera Ab | 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity |
| US11660303B2 (en) | 2016-07-11 | 2023-05-30 | Kancera Ab | 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity |
| CN110139669A (zh) | 2016-11-03 | 2019-08-16 | 朱诺治疗学股份有限公司 | T细胞疗法和btk抑制剂的组合疗法 |
| BR112020022185A2 (pt) | 2018-05-03 | 2021-02-02 | Juno Therapeutics Inc | terapia de combinação de uma terapia de células t do receptor de antígeno quimérico (car) e um inibidor de quinase |
| JP2023513624A (ja) | 2020-02-18 | 2023-03-31 | バイエル・アクチエンゲゼルシヤフト | 殺有害生物剤としてのヘテロアリール－トリアゾール化合物 |
| CN113582988B (zh) * | 2020-04-30 | 2025-09-09 | 正大天晴药业集团股份有限公司 | 吡啶并环类化合物及其医药用途 |
| US20250302954A1 (en) | 2022-05-11 | 2025-10-02 | Celgene Corporation | Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3985891A (en) | 1973-02-03 | 1976-10-12 | Boehringer Ingelheim Gmbh | 2-Phenyl-imidazo (4,5-b)pyridines and salts thereof |
| DE3037464A1 (de) | 1980-10-03 | 1982-05-19 | Dr. Karl Thomae Gmbh, 7950 Biberach | 6-hydroxy-2-phenyl-imidazo 4,5-b zu pyridine, ihre herstellung und diese sie enthaltende arzneimittel |
| US5296591A (en) * | 1990-12-31 | 1994-03-22 | Fujisawa Pharmaceutical Co., Ltd. | Trifluoromethylketone derivatives, processes for preparation thereof and use thereof |
| EP1294718A2 (en) * | 2000-06-14 | 2003-03-26 | Warner-Lambert Company Llc | 6,5-fused bicyclic heterocycles |
| WO2002048152A2 (en) * | 2000-12-12 | 2002-06-20 | Neurogen Corporation | Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
-
2002
- 2002-08-14 SE SE0202462A patent/SE0202462D0/xx unknown
-
2003
- 2003-08-13 MX MXPA05001581A patent/MXPA05001581A/es unknown
- 2003-08-13 AU AU2003251272A patent/AU2003251272A1/en not_active Abandoned
- 2003-08-13 KR KR1020057002263A patent/KR20060005333A/ko not_active Withdrawn
- 2003-08-13 CN CNB03823193XA patent/CN100358893C/zh not_active Expired - Fee Related
- 2003-08-13 AT AT03788216T patent/ATE370138T1/de not_active IP Right Cessation
- 2003-08-13 DE DE60315674T patent/DE60315674T2/de not_active Expired - Fee Related
- 2003-08-13 EP EP03788216A patent/EP1539759B1/en not_active Expired - Lifetime
- 2003-08-13 BR BR0313461-0A patent/BR0313461A/pt not_active IP Right Cessation
- 2003-08-13 CA CA002495511A patent/CA2495511A1/en not_active Abandoned
- 2003-08-13 ES ES03788216T patent/ES2290538T3/es not_active Expired - Lifetime
- 2003-08-13 NZ NZ538156A patent/NZ538156A/en unknown
- 2003-08-13 JP JP2004529004A patent/JP2006503010A/ja not_active Withdrawn
- 2003-08-13 WO PCT/SE2003/001279 patent/WO2004016611A1/en not_active Ceased
- 2003-08-13 US US10/524,204 patent/US7410966B2/en not_active Expired - Fee Related
-
2005
- 2005-01-20 IL IL16641305A patent/IL166413A0/xx unknown
- 2005-01-31 ZA ZA200500887A patent/ZA200500887B/xx unknown
- 2005-03-11 NO NO20051265A patent/NO20051265L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006503010A5 (OSRAM) | ||
| AU2005216904B2 (en) | Modulation of inflammatory and metastatic processes | |
| US7470709B2 (en) | Benzimidazole quinolinones and uses thereof | |
| TWI248932B (en) | Respiratory syncytial virus replication inhibitors | |
| US7642278B2 (en) | Indazole benzimidazole compounds | |
| AU2018282747A1 (en) | Compounds for modulating S1P1 activity and methods of using the same | |
| RU2003106193A (ru) | Способ лечения аллергий с использованием замещенных пиразолов | |
| IL187690A (en) | Derivatives 1, 2, 4 - Triazolo - 1, 6 - Naphthiridines as inhibitors of AKT activity for use in the preparation of drugs for the treatment of cancer | |
| PT1497287E (pt) | Derivados de quinolinona em combinação com 5-fu ou cpt-11 para utilização no tratamento do câncro | |
| JP2013515032A5 (OSRAM) | ||
| RU2003107016A (ru) | Замещенные пиразолы | |
| JP2009510161A5 (OSRAM) | ||
| JP2010523576A5 (OSRAM) | ||
| RU2015124917A (ru) | Новые бициклические фенилпиридины/пиразины для лечения рака | |
| JP2013539777A5 (OSRAM) | ||
| RU2005127335A (ru) | Новые производные цикломочевины, их получение и их фармацевтическое применение в качестве ингибиторов киназ | |
| SK287181B6 (sk) | Chinolinónový derivát a jeho použitie a farmaceutický prostriedok s obsahom tohto derivátu | |
| HRP20110804T1 (hr) | Benzocikloheptapiridini kao inhibitori receptora tirozin kinaze met | |
| JP2016504387A (ja) | Ｗｎｔシグナル伝達経路の３−（ベンゾイミダゾール−２−イル）−インダゾール阻害剤およびそれらの治療的使用 | |
| JP2017512786A (ja) | ＴｒｋＡキナーゼ阻害薬、その組成物および方法 | |
| JP2018507235A (ja) | ステロール調節エレメント結合タンパク質（ｓｒｅｂｐ）阻害剤 | |
| WO2013117645A1 (en) | Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases | |
| JPWO2019216294A5 (OSRAM) | ||
| JPWO2023066825A5 (OSRAM) | ||
| JP2002338497A (ja) | 抑うつ及び不安のための併合療法 |